Vivek Narayan - Concepedia

Author

Vivek Narayan

Also Known As

Lauren E. Schwartz, V Narayan, V. Narayan, V.K. Narayan, Vikram M. Narayan, Vikram Madhavan Narayan, Vikram Narayan, Vishnu Narayan, Vivek K Narayan, Vivek K. Narayan

300

Publications

3.7K

Citations

H-Index

Concepts

All Affiliations

University of Pennsylvania University of Michigan The University of Texas MD Anderson Cancer Center University of Utah Massachusetts General Hospital

About

Vivek Narayan is an author at University of Pennsylvania specializing in medicine, oncology, and urology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	20	1.9K
2	Immunology	8	8	721
3	Cell Biology	2	2	49
4	Social Sciences	1	1	17
5	Cardiothoracic Surgery	1	1	79

Vivek Narayan

Publications

3.1K

Citations

H-Index

Page 1

	Year	Citations
PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial Vivek Narayan, Julie S. Barber-Rotenberg, In-Young Jung, Nature Medicine UrologyCancer ImmunosurveillanceGenitourinary CancerMedicineImmunology	2022	455
Nivolumab Plus Ipilimumab for Metastatic Castration-Resistant Prostate Cancer: Preliminary Analysis of Patients in the CheckMate 650 Trial Padmanee Sharma, Russell K. Pachynski, Vivek Narayan, Cancer Cell UrologyOncologyNivolumab Plus IpilimumabGenitourinary CancerMedicine	2020	371
A comparison of sunitinib with cabozantinib, crizotinib, and savolitinib for treatment of advanced papillary renal cell carcinoma: a randomised, open-label, phase 2 trial Sumanta K. Pal, Catherine M. Tangen, Ian M. Thompson, The Lancet UrologyGenitourinary CancerMedicinePharmacologyPharmacotherapy	2021	266
Cabozantinib in advanced non-clear-cell renal cell carcinoma: a multicentre, retrospective, cohort study Nieves Martínez Chanzá, Wanling Xie, Mehmet Asım Bilen, The Lancet Oncology UrologyGenitourinary CancerKidney ResearchMedicineRenal Pathology	2019	173
Changes in Cardiovascular Biomarkers With Breast Cancer Therapy and Associations With Cardiac Dysfunction Biniyam G. Demissei, Rebecca A. Hubbard, Liyong Zhang, Journal of the American Heart Association	2020	159
Arginine-Nitric Oxide Metabolites and Cardiac Dysfunction in Patients With Breast Cancer Brian S. Finkelman, Mary Putt, Teresa Wang, Journal of the American College of Cardiology Heart FailureArginine-nitric Oxide MetabolitesCardiovascular DiseaseMedicineBreast Cancer	2017	123
Evaluation of the Safety and Efficacy of Immunotherapy Rechallenge in Patients With Renal Cell Carcinoma Praful Ravi, Charlene Mantia, Christopher Su, JAMA Oncology	2020	120
BLIMP1 and NR4A3 transcription factors reciprocally regulate antitumor CAR T cell stemness and exhaustion In-Young Jung, Vivek Narayan, Sierra McDonald, Science Translational Medicine	2022	120
Initial results from a phase II study of nivolumab (NIVO) plus ipilimumab (IPI) for the treatment of metastatic castration-resistant prostate cancer (mCRPC; CheckMate 650). Padmanee Sharma, Russell K. Pachynski, Vivek Narayan, Journal of Clinical Oncology Cancer ManagementImmunologyPhase Ii StudyPharmacotherapyImmunotherapeutics	2019	91
Assessment and Management of Cardiovascular Risk Factors Among US Veterans With Prostate Cancer Lova Sun, Ravi B. Parikh, Rebecca A. Hubbard, JAMA Network Open	2021	80

Page 1